Targeted Intraoperative Radiotherapy (TARGIT-IORT) in Breast Cancer Surgery
DOI:
https://doi.org/10.54097/rg2rnp09Keywords:
Breast cancer; TARGIT-IORT; targeted intraoperative radiotherapy.Abstract
According to the WHO, breast cancer (BC) has become the largest increase cancer in the world. The vast majority of cancers require radiotherapy and it is the mainstream treatment modality. Although there are numerous treatments, it still does not have a suitable one because of the side effects of radiotherapy. To reduce the harm to the body, people are attending to find a fewer side-effect one. Nowadays, the intraoperative radiation therapy（IORT）is starting to come into its own. TARGIT-IORT is a type of accelerated partial breast irradiation (APBI). The differences between TARGIT-IORT and traditional radiation are the localized radiating space and radiotherapy can be administered during surgery. Researchers have now found that it has a precise radiation range and can be performed simultaneously during surgery. Besides, it performs even better than traditional radiation therapy in various aspects. This is certainly a new trend in breast cancer treatment. TARGIT-IORT is expected to be the next trend in the treatment of BC.
Downloads
References
Shamsabadi, R., Baghani, H. R., Mowlavi, A. A. & Azadegan, B. Effective energy assessment during breast cancer intraoperative radiotherapy by low-energy X-rays: A Monte Carlo study. Radiat Environ Biophys 60, 125–134 (2021).
R, G. et al. Prevalence of and factors associated with persistent pain following breast cancer surgery. JAMA 302, (2009).
Form or function? Part 2. Objective cosmetic and functional correlates of quality of life in women treated with breast-conserving surgical procedures and radiotherapy - PubMed. https://pubmed.ncbi.nlm.nih.gov/11413516/.
Welzel, G. et al. Radiation-related quality of life parameters after targeted intraoperative radiotherapy versus whole breast radiotherapy in patients with breast cancer: results from the randomized phase III trial TARGIT-A. Radiat Oncol 8, 9 (2013).
Vaidya, J. S. et al. Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial. Lancet 383, 603–613 (2014).
Vaidya, J. S. et al. New clinical and biological insights from the international TARGIT-A randomised trial of targeted intraoperative radiotherapy during lumpectomy for breast cancer. Br J Cancer 125, 380–389 (2021).
Clarke, M. et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366, 2087–2106 (2005).
Vaidya, J. S. et al. Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial. BMJ 370, m2836 (2020).
Munshi, A. et al. Factors influencing cosmetic outcome in breast conservation. Clin Oncol (R Coll Radiol) 21, 285–293 (2009).
Keshtgar, M. R. S. et al. Objective assessment of cosmetic outcome after targeted intraoperative radiotherapy in breast cancer: results from a randomised controlled trial. Breast Cancer Res Treat 140, 519–525 (2013).
Coombs, N. J. et al. Environmental and social benefits of the targeted intraoperative radiotherapy for breast cancer: data from UK TARGIT-A trial centres and two UK NHS hospitals offering TARGIT IORT. BMJ Open 6, e010703 (2016).
Gillman, J., Chun, J., Schwartz, S., Schnabel, F. & Moy, L. The relationship of obesity, mammographic breast density, and magnetic resonance imaging in patients with breast cancer. Clin Imaging 40, 1167–1172 (2016).
Brown, A. et al. Targeted Intraoperative Radiotherapy (TARGIT-IORT) for Early-Stage Invasive Breast Cancer: A Single Institution Experience. Front. Oncol. 12, 788213 (2022).
Male breast cancer: a disease distinct from female breast cancer | Breast Cancer Research and Treatment. https://link.springer.com/article/10.1007/s10549-018-4921-9.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Highlights in Science, Engineering and Technology
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
